2015 Patients Pharmacology Safety 
European Pharmaceutical Review
MARCH 11, 2024
In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. 3 But that paradigm is rapidly changing. Internet] 2023.
Pharmaceutical Technology
OCTOBER 10, 2022
The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). Despite the recognized need and demand for options to treat female sexual dysfunction, several safety and access issues associated with the use of available options.
Expert insights. Personalized for you.
89 
Let's personalize your content